Tobacco Product Use Among Adults — United States, 2017

Cigarette smoking harms nearly every organ of the body and causes adverse health consequences, including heart disease, stroke, and multiple types of cancer (1). Although cigarette smoking among U. S. adults has declined considerably, tobacco products have evolved in recent years to include various combustible, noncombustible, and electronic products (1, 2). To assess recent national estimates of tobacco product use among U. S. adults aged ≥18 years, CDC, the Food and Drug Administration (FDA), and the National Institutes of Health's National Cancer Institute analyzed data from the 2017 National Health Interview Survey (NHIS). In 2017, an estimated 47. 4 million U. S. adults (19. 3%) currently used any tobacco product, including cigarettes (14. 0%; 34. 3 million) ; cigars, cigarillos, or filtered little cigars (3. 8%; 9. 3 million) ; electronic cigarettes (e-cigarettes) (2. 8%; 6. 9 million) ; smokeless tobacco (2. 1%; 5. 1 million) ; and pipes, water pipes, or hookahs (1. 0%; 2. 6 million). Among current tobacco product users, 86. 7% (41. 1 million) smoked combustible tobacco products, and 19. 0% (9. 0 million) used ≥2 tobacco products. By univariate analyses, the prevalence of current use of any tobacco product was higher among males than among females; adults aged <65 years than among those aged ≥65 years; non-Hispanic American Indian/Alaska Natives, whites, blacks, or multiracial adults than among Hispanics or non-Hispanic Asians; adults who lived in the South or Midwest than among those in the West or Northeast; adults who had a general educational development certificate (GED) than among those with other levels of education; adults who earned an annual household income of <35, 000 than among those with those with higher income; lesbian, gay, or bisexual adults than among heterosexual/straight adults; and adults who were divorced/separated/widowed or single/never married/not living with a partner than among those who were married/living with a partner. Prevalence was also higher among those who were uninsured, insured by Medicaid, or had some other public insurance than among those with private insurance or Medicare only; those who had a disability/limitation than among those who did not; and those who had serious psychological distress than among those who did not. Full implementation of evidence-based tobacco control interventions that address the diversity of tobacco products used by U. S. adults, in coordination with regulation of tobacco product manufacturing, marketing, and sales, can reduce tobacco-related disease and death in the United States (1-3).